Key result
Diagnostic assays for primary HCMV infection in mothers and congenital infection in fetuses/newborns are well established and key for management in the absence of a vaccine.
Answers are grounded in this paper and cite their sources.
In the absence of a vaccine, accurate diagnosis of primary HCMV infection in mothers and congenital infection in fetuses/newborns remains critical for clinical management.
BACKGROUND: The socio-economic burden associated with congenital human cytomegalovirus (HCMV) infection is well recognized. Nevertheless, women are neither informed nor tested for HCMV antibody, and in the absence of screening, HCMV infections proceed mostly undiagnosed during pregnancy. METHODS: Knowledge has accumulated concerning both the natural history of HCMV infection and the availability of diagnostic tests. RESULTS: Different assays for the diagnosis in the mother, fetus and newborn are well established. In addition, positive and negative predictive values of different assays for prenatal diagnosis have improved over time. CONCLUSIONS: Without an HCMV vaccine, diagnosis of primary infection in the mother and of congenital infection in the fetus/newborn are key factors for management of congenital HCMV infection.
No takes yet. Share an insight, caveat, or question.
Revello et al. (2008) conducted a review in congenital human cytomegalovirus (HCMV) infection. Diagnostic assays for HCMV was evaluated. Diagnostic assays for primary HCMV infection in mothers and congenital infection in fetuses/newborns are well established and key for management in the absence of a vaccine.
Synapse has enriched 10 related papers. Consider them for comparative context: